TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T19160	Group IIA phospholipase A2	D00XQO	MANOALIDE	Phase 2	6437368	C25H36O5	416.5	CC1=C(C(CCC1)(C)C)CC/C(=C/CCC2=CC[C@@H](O[C@H]2O)C3=CC(=O)O[C@H]3O)/C	IC50 = 93200 nM	Poor binder
T19160	Group IIA phospholipase A2	B05PVI	(1-Benzyl-5-methoxy-2-propyl-1H-indol-3-yl)-acetic acid hydrazide	Investigative	10569958	C21H25N3O2	351.4	CCCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OC)CC(=O)NN	IC50 = 70500 nM	Poor binder
T19160	Group IIA phospholipase A2	B0J7SO	3-{4-[(4-Hexadecylpiperazin-1-yl)methyl]phenyl}-4,5-dihydro-1,2,4-oxadiazol-5-one	Investigative	135899008	C29H48N4O2	484.7	CCCCCCCCCCCCCCCCN1CCN(CC1)CC2=CC=C(C=C2)C3=NOC(=O)N3	IC50 ~ 100000 nM	Poor binder
T19160	Group IIA phospholipase A2	B0V2FD	(2R)-2-[[(2R)-2-[[(2R)-2-[[2-[[(2R)-2-[[2-[[5-(2-Benzamido-4-methyl-1,3-thiazol-5-yl)-1H-pyrazole-3-carbonyl]amino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-carboxypropanoyl]amino]butanedioic acid	Investigative	71533476	C37H45N13O15S	943.9	CC1=C(SC(=N1)NC(=O)C2=CC=CC=C2)C3=CC(=NN3)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CC(=O)O)C(=O)N[C@H](CC(=O)O)C(=O)O	IC50 = 71000 nM	Poor binder
T19160	Group IIA phospholipase A2	B10QAP	3-[Acetyl-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)amino]propanoic acid	Investigative	10788995	C24H25N3O5	435.5	CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2N(CCC(=O)O)C(=O)C)C(=O)C(=O)N	IC50 ~ 100000 nM	Poor binder
T19160	Group IIA phospholipase A2	B1UJS2	2-[5-[2-(4-Phenoxyphenoxy)ethoxy]-1H-indol-3-yl]ethylcarbamic acid	Investigative	71716159	C25H24N2O5	432.5	C1=CC=C(C=C1)OC2=CC=C(C=C2)OCCOC3=CC4=C(C=C3)NC=C4CCNC(=O)O	IC50 = 71000 nM	Poor binder
T19160	Group IIA phospholipase A2	B1WCL8	4-(1-Benzyl-3-oxamoylindol-5-yl)oxybutanoic acid	Investigative	10619750	C21H20N2O5	380.4	C1=CC=C(C=C1)CN2C=C(C3=C2C=CC(=C3)OCCCC(=O)O)C(=O)C(=O)N	IC50 = 62000 nM	Poor binder
T19160	Group IIA phospholipase A2	B2OX9A	3-(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-5-yloxy)-benzoic acid	Investigative	10764272	C25H22N2O4	414.5	CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OC4=CC=CC(=C4)C(=O)O)CC(=O)N	IC50 ~ 110000 nM	Poor binder
T19160	Group IIA phospholipase A2	B2VX9Q	3-[4-(2,3-Diheptoxypropoxy)phenyl]-4H-1,2,4-oxadiazol-5-one	Investigative	135540873	C25H40N2O5	448.6	CCCCCCCOCC(COC1=CC=C(C=C1)C2=NOC(=O)N2)OCCCCCCC	IC50 = 50900 nM	Poor binder
T19160	Group IIA phospholipase A2	B4J7HX	(2R)-2-[[2-[[(2R)-2-[[2-[[5-(2-Benzamido-4-methyl-1,3-thiazol-5-yl)-1H-pyrazole-3-carbonyl]amino]acetyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]butanedioic acid	Investigative	71718250	C29H35N11O9S	713.7	CC1=C(SC(=N1)NC(=O)C2=CC=CC=C2)C3=CC(=NN3)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(=O)O)C(=O)O	IC50 = 155000 nM	Poor binder
T19160	Group IIA phospholipase A2	B4LV8Z	{2-[((4S,5R)-3-Dodecanoyl-2-oxo-4-propyl-oxazolidin-5-ylmethoxy)-hydroxy-phosphoryloxy]-ethyl}-trimethyl-ammonium	Investigative	44344293	C24H47N2O7P	506.6	CCCCCCCCCCCC(=O)N1[C@H]([C@H](OC1=O)COP(=O)([O-])OCC[N+](C)(C)C)CCC	IC50 = 52900 nM	Poor binder
T19160	Group IIA phospholipase A2	B5L8YW	3-[4-[(2-Oxo-4-tetradecanoylpiperazin-1-yl)methyl]phenyl]-4H-1,2,4-oxadiazol-5-one	Investigative	136086771	C27H40N4O4	484.6	CCCCCCCCCCCCCC(=O)N1CCN(C(=O)C1)CC2=CC=C(C=C2)C3=NOC(=O)N3	IC50 ~ 75000 nM	Poor binder
T19160	Group IIA phospholipase A2	B68WOI	3-{4-[(4-Tetradecylpiperazin-1-yl)methyl]phenyl}-4,5-dihydro-1,2,4-oxadiazol-5-one	Investigative	135899007	C27H44N4O2	456.7	CCCCCCCCCCCCCCN1CCN(CC1)CC2=CC=C(C=C2)C3=NOC(=O)N3	IC50 ~ 100000 nM	Poor binder
T19160	Group IIA phospholipase A2	B6BLQ9	3-[4-[2,3-Bis(4-phenylbutoxy)propoxy]phenyl]-4H-1,2,4-oxadiazol-5-one	Investigative	135540872	C31H36N2O5	516.6	C1=CC=C(C=C1)CCCCOCC(COC2=CC=C(C=C2)C3=NOC(=O)N3)OCCCCC4=CC=CC=C4	IC50 = 76700 nM	Poor binder
T19160	Group IIA phospholipase A2	B7COD4	2-(1-Benzyl-2-ethyl-4-methoxy-1H-indol-3-yl)-2-hydroxy-acetamide	Investigative	10735747	C20H22N2O3	338.4	CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OC)C(C(=O)N)O	IC50 = 53000 nM	Poor binder
T19160	Group IIA phospholipase A2	B7X1DW	4-[4-[5-[[5-[4-(4-Carboxy-3-methoxy-2,5,6-trimethylphenoxy)carbonyl-3-methoxy-2,5,6-trimethylphenoxy]carbonyl-2,4-dimethoxy-3,6-dimethylphenyl]methyl]-2,4-dimethoxy-3,6-dimethylbenzoyl]oxy-2-methoxy-3,5,6-trimethylbenzoyl]oxy-2-methoxy-3,5,6-trimethylbenzoic acid	Investigative	16144090	C67H76O20	1201.3	CC1=C(C(=C(C(=C1C(=O)O)OC)C)OC(=O)C2=C(C(=C(C(=C2C)C)OC(=O)C3=C(C(=C(C(=C3C)CC4=C(C(=C(C(=C4OC)C)OC)C(=O)OC5=C(C(=C(C(=C5C)C)C(=O)OC6=C(C(=C(C(=C6C)C)C(=O)O)OC)C)OC)C)C)OC)C)OC)C)OC)C	IC50 = 190000 nM	Poor binder
T19160	Group IIA phospholipase A2	B8HRO9	3-{4-[(4-Tetradecylpiperazin-1-yl)carbonyl]phenyl}-4,5-dihydro-1,2,4-oxadiazol-5-one	Investigative	135899013	C27H42N4O3	470.6	CCCCCCCCCCCCCCN1CCN(CC1)C(=O)C2=CC=C(C=C2)C3=NOC(=O)N3	IC50 ~ 100000 nM	Poor binder
T19160	Group IIA phospholipase A2	BASF96	3-{4-[(4-Hexadecylpiperazin-1-yl)carbonyl]phenyl}-4,5-dihydro-1,2,4-oxadiazol-5-one	Investigative	135899014	C29H46N4O3	498.7	CCCCCCCCCCCCCCCCN1CCN(CC1)C(=O)C2=CC=C(C=C2)C3=NOC(=O)N3	IC50 ~ 100000 nM	Poor binder
T19160	Group IIA phospholipase A2	BBR76C	(3-{[3-(2-Amino-2-Oxoethyl)-1-Benzyl-2-Ethyl-1h-Indol-5-Yl]oxy}propyl)phosphonic Acid	Investigative	155922	C22H27N2O5P	430.4	CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OCCCP(=O)(O)O)CC(=O)N	IC50 = 91100 nM	Poor binder
T19160	Group IIA phospholipase A2	BC1O4H	Methyl 2-(4-butoxyphenyl)-6-methoxyquinoline-4-carboxylate	Investigative	56668640	C22H23NO4	365.4	CCCCOC1=CC=C(C=C1)C2=NC3=C(C=C(C=C3)OC)C(=C2)C(=O)OC	IC50 = 57000 nM	Poor binder
T19160	Group IIA phospholipase A2	BC1WV6	(4As,6S,6aS,7S,10bR)-7,8-Bis-hydroxymethyl-1,1,4a,6a,10b-pentamethyl-1,2,3,4,4a,4b,5,6,6a,7,10,10a,10b,11,12,12a-hexadecahydro-chrysen-6-ol	Investigative	44298799	C25H42O3	390.6	C[C@]12CCCC(C1CC[C@@]3(C2C[C@@H]([C@]4(C3CC=C([C@@H]4CO)CO)C)O)C)(C)C	IC50 = 50000 nM	Poor binder
T19160	Group IIA phospholipase A2	BDCH72	4-[4-[2,4-Dihydroxy-3,6-dimethyl-5-[[(2-oxo-2-phenylmethoxyethyl)amino]methyl]benzoyl]oxy-2-hydroxy-3,5,6-trimethylbenzoyl]oxy-2-hydroxy-3,5,6-trimethylbenzoic acid	Investigative	122197354	C39H41NO12	715.7	CC1=C(C(=C(C(=C1C(=O)O)O)C)OC(=O)C2=C(C(=C(C(=C2C)C)OC(=O)C3=C(C(=C(C(=C3C)CNCC(=O)OCC4=CC=CC=C4)O)C)O)C)O)C	IC50 = 140000 nM	Poor binder
T19160	Group IIA phospholipase A2	BG37KY	1-[[4-(5-Oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]methyl]-4-tetradecylpiperazine-2,5-dione	Investigative	136086773	C27H40N4O4	484.6	CCCCCCCCCCCCCCN1CC(=O)N(CC1=O)CC2=CC=C(C=C2)C3=NOC(=O)N3	IC50 = 57000 nM	Poor binder
T19160	Group IIA phospholipase A2	BG6AF0	[Acetyl-(3-aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yl)-amino]-acetic acid	Investigative	11796442	C23H23N3O5	421.4	CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2N(CC(=O)O)C(=O)C)C(=O)C(=O)N	IC50 ~ 100000 nM	Poor binder
T19160	Group IIA phospholipase A2	BH8PU5	N-Methyl-2-(1-benzyl-2-methyl-5-methoxy-1H-indol-3-yl)acetamide	Investigative	10591942	C20H22N2O2	322.4	CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OC)CC(=O)NC	IC50 = 141800 nM	Poor binder
T19160	Group IIA phospholipase A2	BIG3H9	2-(1-Benzyl-6-methoxy-2-methyl-1H-indol-3-yl)-2-hydroxy-acetamide	Investigative	10829826	C19H20N2O3	324.4	CC1=C(C2=C(N1CC3=CC=CC=C3)C=C(C=C2)OC)C(C(=O)N)O	IC50 = 120900 nM	Poor binder
T19160	Group IIA phospholipase A2	BJX20B	5-Benzyloxytryptamine hydrochloride	Investigative	2828785	C17H19ClN2O	302.8	C1=CC=C(C=C1)COC2=CC3=C(C=C2)NC=C3CCN.Cl	IC50 = 52000 nM	Poor binder
T19160	Group IIA phospholipase A2	BKM6V9	3-[4-(3-Phenylmethoxy-2-tetradecoxypropoxy)phenyl]-4H-1,2,4-oxadiazol-5-one	Investigative	135540837	C32H46N2O5	538.7	CCCCCCCCCCCCCCOC(COCC1=CC=CC=C1)COC2=CC=C(C=C2)C3=NOC(=O)N3	IC50 ~ 100000 nM	Poor binder
T19160	Group IIA phospholipase A2	BM7QU6	1-Benzyl-5-methoxy-2-methyl-3-(2H-tetrazol-5-ylmethyl)-1H-indole	Investigative	10759068	C19H19N5O	333.4	CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OC)CC4=NNN=N4	IC50 = 84700 nM	Poor binder
T19160	Group IIA phospholipase A2	BMSX43	Bis[3-[[4-[(4-carboxy-3-methoxy-2,5,6-trimethylphenoxy)carbonyl]-3-methoxy-2,5,6-trimethylphenoxy]carbonyl]-4-methoxyphenyl] ether	Investigative	16143405	C60H62O19	1087.1	CC1=C(C(=C(C(=C1C(=O)O)OC)C)OC(=O)C2=C(C(=C(C(=C2C)C)OC(=O)C3=C(C=CC(=C3)OC4=CC(=C(C=C4)OC)C(=O)OC5=C(C(=C(C(=C5C)C)C(=O)OC6=C(C(=C(C(=C6C)C)C(=O)O)OC)C)OC)C)OC)C)OC)C	IC50 = 100000 nM	Poor binder
T19160	Group IIA phospholipase A2	BN0I3E	6-(4-Oxo-2-phenyl-chromen-6-yl)-2-phenyl-chromen-4-one	Investigative	381598	C30H18O4	442.5	C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)C4=CC5=C(C=C4)OC(=CC5=O)C6=CC=CC=C6	IC50 = 69300 nM	Poor binder
T19160	Group IIA phospholipase A2	BN4TG9	Bis[3-[[4-[(4-carboxy-3-methoxy-2,5,6-trimethylphenoxy)carbonyl]-3-methoxy-2,5,6-trimethylphenoxy]carbonyl]-4-methoxyphenyl] sulfide	Investigative	16138504	C60H62O18S	1103.2	CC1=C(C(=C(C(=C1C(=O)O)OC)C)OC(=O)C2=C(C(=C(C(=C2C)C)OC(=O)C3=C(C=CC(=C3)SC4=CC(=C(C=C4)OC)C(=O)OC5=C(C(=C(C(=C5C)C)C(=O)OC6=C(C(=C(C(=C6C)C)C(=O)O)OC)C)OC)C)OC)C)OC)C	IC50 = 130000 nM	Poor binder
T19160	Group IIA phospholipase A2	BNQ98M	3-(1-Benzyl-3-carbamoylmethyl-2-ethyl-1H-indol-5-yloxy)-propane-1-sulfonic acid	Investigative	10598732	C22H26N2O5S	430.5	CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OCCCS(=O)(=O)O)CC(=O)N	IC50 = 135000 nM	Poor binder
T19160	Group IIA phospholipase A2	BNY3U1	[3-(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-5-yloxy)-propyl-]-phosphonic acid	Investigative	3711	C21H25N2O5P	416.4	CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OCCCP(=O)(O)O)CC(=O)N	IC50 = 67000 nM	Poor binder
T19160	Group IIA phospholipase A2	BO0GV5	2-(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)-octanoic acid hydrazide	Investigative	10763924	C25H33N3O2	407.5	CCCCCCC(C1=C(N(C2=C1C=C(C=C2)OC)CC3=CC=CC=C3)C)C(=O)NN	IC50 = 101200 nM	Poor binder
T19160	Group IIA phospholipase A2	BO5HM1	2-(1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)-acetamidine	Investigative	10852262	C19H21N3O	307.4	CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OC)CC(=N)N	IC50 = 64700 nM	Poor binder
T19160	Group IIA phospholipase A2	BO8P6B	(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-4-Amino-2-[[(2R)-2-[[(2R)-2-[(3-chloro-5H-indazolo[2,3-a][3,1]benzoxazine-8-carbonyl)amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-oxobutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid	Investigative	71718251	C52H62ClN15O11	1108.6	C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CC(=O)N)NC(=O)[C@@H](CCCN=C(N)N)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)C3=CC4=C5N(C6=C(CO5)C=C(C=C6)Cl)N=C4C=C3	IC50 = 85000 nM	Poor binder
T19160	Group IIA phospholipase A2	BOXQ56	4-(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-5-yloxy)-butyric acid	Investigative	3710	C22H24N2O4	380.4	CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OCCCC(=O)O)CC(=O)N	IC50 = 69000 nM	Poor binder
T19160	Group IIA phospholipase A2	BRA0D5	(1-Benzyl-3-carbamoylmethyl-2-methyl-1H-indol-4-yloxymethyl)-phosphonic acid	Investigative	10762842	C19H21N2O5P	388.4	CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCP(=O)(O)O)CC(=O)N	IC50 = 73500 nM	Poor binder
T19160	Group IIA phospholipase A2	BS27AB	4-[4-[3-[[5-[4-(4-Carboxy-3-methoxy-2,5,6-trimethylphenoxy)carbonyl-3-methoxy-2,5,6-trimethylphenoxy]carbonyl-2,4-dihydroxy-3,6-dimethylphenyl]methyl]-2,4-dihydroxy-6-methylbenzoyl]oxy-2-methoxy-3,5,6-trimethylbenzoyl]oxy-2-methoxy-3,5,6-trimethylbenzoic acid	Investigative	16135012	C62H66O20	1131.2	CC1=CC(=C(C(=C1C(=O)OC2=C(C(=C(C(=C2C)C)C(=O)OC3=C(C(=C(C(=C3C)C)C(=O)O)OC)C)OC)C)O)CC4=C(C(=C(C(=C4O)C)O)C(=O)OC5=C(C(=C(C(=C5C)C)C(=O)OC6=C(C(=C(C(=C6C)C)C(=O)O)OC)C)OC)C)C)O	IC50 = 76000 nM	Poor binder
T19160	Group IIA phospholipase A2	BS3DW8	2-(1-Benzyl-2-methyl-5-methoxy-1H-indol-3-yl)thioacetamide	Investigative	10711124	C19H20N2OS	324.4	CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OC)CC(=S)N	IC50 = 74100 nM	Poor binder
T19160	Group IIA phospholipase A2	BS5D3M	2-[5-[(3-Phenoxyphenyl)methoxy]-1H-indol-3-yl]ethylcarbamic acid	Investigative	71720417	C24H22N2O4	402.4	C1=CC=C(C=C1)OC2=CC=CC(=C2)COC3=CC4=C(C=C3)NC=C4CCNC(=O)O	IC50 = 58000 nM	Poor binder
T19160	Group IIA phospholipase A2	BS6P4T	1H-Indole-3-acetic acid, 5-methoxy-2-methyl-1-(phenylmethyl)-, methyl ester	Investigative	3044911	C20H21NO3	323.4	CC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OC)CC(=O)OC	IC50 = 115800 nM	Poor binder
T19160	Group IIA phospholipase A2	BTOD30	2-[5-[(4-Phenylphenyl)methoxy]-1H-indol-3-yl]ethylcarbamic acid	Investigative	71719202	C24H22N2O3	386.4	C1=CC=C(C=C1)C2=CC=C(C=C2)COC3=CC4=C(C=C3)NC=C4CCNC(=O)O	IC50 = 53000 nM	Poor binder
T19160	Group IIA phospholipase A2	BVM9G8	3-[4-(3-Hydroxy-2-tetradecoxypropoxy)phenyl]-4H-1,2,4-oxadiazol-5-one	Investigative	135540876	C25H40N2O5	448.6	CCCCCCCCCCCCCCOC(CO)COC1=CC=C(C=C1)C2=NOC(=O)N2	IC50 = 56000 nM	Poor binder
T19160	Group IIA phospholipase A2	BXG5J0	Ubenimex	Investigative	72172	C16H24N2O4	308.37	CC(C)C[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](CC1=CC=CC=C1)N)O	IC50 ~ 100000 nM	Poor binder
T19160	Group IIA phospholipase A2	BXWG71	Bis[3-[[4-[(4-carboxy-3-methoxy-2,5,6-trimethylphenoxy)carbonyl]-3-methoxy-2,5,6-trimethylphenoxy]carbonyl]-4-methoxyphenyl] sulfone	Investigative	10558196	C60H62O20S	1135.2	CC1=C(C(=C(C(=C1C(=O)O)OC)C)OC(=O)C2=C(C(=C(C(=C2C)C)OC(=O)C3=C(C=CC(=C3)S(=O)(=O)C4=CC(=C(C=C4)OC)C(=O)OC5=C(C(=C(C(=C5C)C)C(=O)OC6=C(C(=C(C(=C6C)C)C(=O)O)OC)C)OC)C)OC)C)OC)C	IC50 = 69000 nM	Poor binder
T19160	Group IIA phospholipase A2	BZR30O	4-(1-Benzyl-3-carbamoylmethyl-2-ethyl-1H-indol-5-yloxy)-butyric acid	Investigative	10157472	C23H26N2O4	394.5	CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC(=C2)OCCCC(=O)O)CC(=O)N	IC50 = 94000 nM	Poor binder
T19160	Group IIA phospholipase A2	D05LWK	[6,4''']biflavone	Investigative	44410408	C30H18O4	442.5	C1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)C4=CC=C(C=C4)C5=CC(=O)C6=CC=CC=C6O5	IC50 = 63900 nM	Poor binder
T19160	Group IIA phospholipase A2	D0C8MT	2-(7-(benzyloxy)-1H-indol-3-yl)ethanamine	Investigative	260806	C17H18N2O	266.34	C1=CC=C(C=C1)COC2=CC=CC3=C2NC=C3CCN	IC50 = 52500 nM	Poor binder